| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.006 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |